Presenting Author: Miyuki Hsing-Chun Hsieh, PhD – Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Tainan, Taiwan
### @@@ Chan-Jung Liu – National Cheng Kung University Hospital ### 2325300###Co-Author######National Cheng Kung University Hospital###Co-Author: Chan-Jung Liu – National Cheng Kung University Hospital
### @@@ Edward Chia-Cheng Lai, PhD (he/him/his) – Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Taiwan ### 1358157###Co-Author###Professor###Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Taiwan###Co-Author: Edward Chia-Cheng Lai, PhD (he/him/his) – Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Taiwan
### he/him/hisPresenting Author: Hugo Jourdain, PhD (he/him/his) – EPI-PHARE, French National Agency for Medicines and Health Products Safety (ANSM) and French National Health Insurance (CNAM), 143-147 Boulevard Anatole France, 93285, Saint-Denis, France
### he/him/his @@@ Léa Hoisnard – EpiDerme ### 2327348###Co-Author######EpiDerme###Co-Author: Léa Hoisnard – EpiDerme
### @@@ Emilie Sbidian – EPI-PHARE, French National Agency for Medicines and Health Products Safety (ANSM) and French National Health Insurance (CNAM), EpiDermE Epidemiology in Dermatology and Evaluation of Therapeutics, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris Est Créteil University, Créteil, France ### 2326731###Co-Author######EPI-PHARE, French National Agency for Medicines and Health Products Safety (ANSM) and French National Health Insurance (CNAM), EpiDermE Epidemiology in Dermatology and Evaluation of Therapeutics, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris Est Créteil University, Créteil, France###Co-Author: Emilie Sbidian – EPI-PHARE, French National Agency for Medicines and Health Products Safety (ANSM) and French National Health Insurance (CNAM), EpiDermE Epidemiology in Dermatology and Evaluation of Therapeutics, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris Est Créteil University, Créteil, France
### @@@ Mahmoud Zureik, Phamacoepidemiology professor – EPI-PHARE, French National Agency for Medicines and Health Products Safety (ANSM) and French National Health Insurance (CNAM), 143-147 Boulevard Anatole France, 93285, Saint-Denis, France ### 1358633###Co-Author###Phamacoepidemiology professor###EPI-PHARE, French National Agency for Medicines and Health Products Safety (ANSM) and French National Health Insurance (CNAM), 143-147 Boulevard Anatole France, 93285, Saint-Denis, France###Co-Author: Mahmoud Zureik, Phamacoepidemiology professor – EPI-PHARE, French National Agency for Medicines and Health Products Safety (ANSM) and French National Health Insurance (CNAM), 143-147 Boulevard Anatole France, 93285, Saint-Denis, France
###Co-Author: Qiaoxi Chen, phD – Brigham and Women's Hospital
### @@@ Daniel E. Singer, MD – Massachusetts General Hospital, Boston, MA ### 1360618###Co-Author###Professor of Medicine, Harvard Medical School###Massachusetts General Hospital, Boston, MA###Co-Author: Daniel E. Singer, MD – Massachusetts General Hospital, Boston, MA
### @@@ Edouard L. Fu – Leiden University Medical Center ### 2325333###Co-Author######Leiden University Medical Center###Co-Author: Edouard L. Fu – Leiden University Medical Center
### @@@ Chun-Ting Yang, PhD – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School ### 2325401###Co-Author###Research fellow###Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School###Co-Author: Chun-Ting Yang, PhD – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School
### @@@ Kevin Pritchard, OT, PhD, OTR – Brigham and Women's Hospital ### 2325379###Presenting Author###Research Fellow###Brigham and Women's Hospital###Presenting Author: Kevin Pritchard, OT, PhD, OTR – Brigham and Women's Hospital
### @@@ Rishi J. Desai, PhD – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, Massachusetts ### 1093509###Co-Author###Associate Professor###Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, Massachusetts###Co-Author: Rishi J. Desai, PhD – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, Massachusetts
### @@@ Kueiyu Joshua Lin, MD, ScD – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School ### 1082840###Co-Author###Assistant Professor###Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School###Co-Author: Kueiyu Joshua Lin, MD, ScD – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School
###Co-Author: Soowoo Back, MPH – Aetion, Inc
### @@@ Bethany Knox, MPH – Aetion, Inc ### 2325675###Co-Author###Scientist###Aetion, Inc###Co-Author: Bethany Knox, MPH – Aetion, Inc
### @@@ Luca Giraldi, PhD, MS – European Medicines Agency (EMA) ### 1991503###Co-Author######European Medicines Agency (EMA)###Co-Author: Luca Giraldi, PhD, MS – European Medicines Agency (EMA)
### @@@ Ciara D. Coakley, MSc – Aetion Germany GmbH ### 1991949###Co-Author###Senior Scientific Analyst###Aetion Germany GmbH###Co-Author: Ciara D. Coakley, MSc – Aetion Germany GmbH
### @@@ Nicolas Deltour, MSc – Aetion Germany GmbH ### 2325676###Co-Author###Vice President, RWE Strategy###Aetion Germany GmbH###Co-Author: Nicolas Deltour, MSc – Aetion Germany GmbH
### @@@ Emmanuelle Jacquot, MD – Aixial ### 2325677###Co-Author######Aixial###Co-Author: Emmanuelle Jacquot, MD – Aixial
### @@@ Hanaya Raad, MPH – Oracle ### 2325678###Co-Author###Project Manager, Real World Evidence###Oracle###Co-Author: Hanaya Raad, MPH – Oracle
### @@@ Lorna Leal, MD, PhD – European Medicines Agency (EMA) ### 1991504###Co-Author###Scientific Specialist###European Medicines Agency (EMA)###Co-Author: Lorna Leal, MD, PhD – European Medicines Agency (EMA)
### @@@ Catherine Cohet, PhD (she/her/hers) – RWE Workstream, Data Analytics & Methods Task Force, European Medicines Agency ### 1655442###Co-Author###Pharmacoepidemiology/RWE Senior Specialist###RWE Workstream, Data Analytics & Methods Task Force, European Medicines Agency###Co-Author: Catherine Cohet, PhD (she/her/hers) – RWE Workstream, Data Analytics & Methods Task Force, European Medicines Agency
### she/her/hers @@@ Elizabeth M. Garry, PhD, MPH (she/her/hers) – Aetion, Inc. ### 1062756###Presenting Author###VP/Head of Scientific Research + Analytics###Aetion, Inc.###Presenting Author: Elizabeth M. Garry, PhD, MPH (she/her/hers) – Aetion, Inc.
### she/her/hersPresenting Author: Núria Mercadé-Besora, MS – University of Oxford
### @@@ Nhung TH Trinh, PharmD, PhD – Pharmacoepidemiology and Drug Safety Research Group, Department of Pharmacy, Faculty of Mathematics and Natural Sciences, University of Oslo, Oslo, Norway ### 1655801###Co-Author###Postdoctoral Fellow###Pharmacoepidemiology and Drug Safety Research Group, Department of Pharmacy, Faculty of Mathematics and Natural Sciences, University of Oslo, Oslo, Norway###Co-Author: Nhung TH Trinh, PharmD, PhD – Pharmacoepidemiology and Drug Safety Research Group, Department of Pharmacy, Faculty of Mathematics and Natural Sciences, University of Oslo, Oslo, Norway
### @@@ Saeed Hayati – Pharmacoepidemiology and Drug Safety Research Group, Department of Pharmacy, Faculty of Mathematics and Natural Sciences, University of Oslo, Oslo, Norway ### 2325297###Co-Author######Pharmacoepidemiology and Drug Safety Research Group, Department of Pharmacy, Faculty of Mathematics and Natural Sciences, University of Oslo, Oslo, Norway###Co-Author: Saeed Hayati – Pharmacoepidemiology and Drug Safety Research Group, Department of Pharmacy, Faculty of Mathematics and Natural Sciences, University of Oslo, Oslo, Norway
### @@@ Berta Raventós, PhD – Erasmus Medical Center ### 1992204###Co-Author###Postdoctoral researcher###Erasmus Medical Center###Co-Author: Berta Raventós, PhD – Erasmus Medical Center
### @@@ Theresa Burkard, PhD (she/her/hers) – University of Oxford ### 1993259###Co-Author###Postdoctoral Data Scientist###University of Oxford###Co-Author: Theresa Burkard, PhD (she/her/hers) – University of Oxford
### she/her/hers @@@ Edward Burn, PhD – University of Oxford ### 1358374###Co-Author###Senior Researcher in Epidemiology and Health Economics###University of Oxford###Co-Author: Edward Burn, PhD – University of Oxford
### @@@ Martí Català, PhD (he/him/his) – University of Oxford ### 1659148###Co-Author###Senior Data Scientist###University of Oxford###Co-Author: Martí Català, PhD (he/him/his) – University of Oxford
### he/him/his @@@ Angela Lupattelli, PhD – Pharmacoepidemiology and Drug Safety Research Group, Department of Pharmacy, Faculty of Mathematics and Natural Sciences, University of Oslo, Oslo, Norway ### 1063068###Co-Author###Professor###Pharmacoepidemiology and Drug Safety Research Group, Department of Pharmacy, Faculty of Mathematics and Natural Sciences, University of Oslo, Oslo, Norway###Co-Author: Angela Lupattelli, PhD – Pharmacoepidemiology and Drug Safety Research Group, Department of Pharmacy, Faculty of Mathematics and Natural Sciences, University of Oslo, Oslo, Norway
### @@@ Laura Pérez-Crespo, PhD – Fundació Institut Universitari per a la recerca a l'Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol) ### 2325409###Co-Author######Fundació Institut Universitari per a la recerca a l'Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol)###Co-Author: Laura Pérez-Crespo, PhD – Fundació Institut Universitari per a la recerca a l'Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol)
### @@@ Hedvig M.E Nordeng, PhD (she/her/hers) – Pharmacoepidemiology and Drug Safety Research Group, Department of Pharmacy, University of Oslo (UiO), Oslo, Norway ### 1358057###Co-Author###Professor###Pharmacoepidemiology and Drug Safety Research Group, Department of Pharmacy, University of Oslo (UiO), Oslo, Norway###Co-Author: Hedvig M.E Nordeng, PhD (she/her/hers) – Pharmacoepidemiology and Drug Safety Research Group, Department of Pharmacy, University of Oslo (UiO), Oslo, Norway
### she/her/hers @@@ Talita Duarte-Salles, PhD – Erasmus MC and IDIAPJGol ### 1358413###Co-Author###Assistant Professor###Erasmus MC and IDIAPJGol###Co-Author: Talita Duarte-Salles, PhD – Erasmus MC and IDIAPJGol
###Presenting Author: Bohee Lee, PharmD, PhD (she/her/hers) – Imperial College London
### she/her/hers @@@ Ernie Wong, PhD – Imperial College London ### 2325343###Co-Author######Imperial College London###Co-Author: Ernie Wong, PhD – Imperial College London
### @@@ Tricia Tan, PhD – Imperial College London ### 2325344###Co-Author######Imperial College London###Co-Author: Tricia Tan, PhD – Imperial College London
### @@@ Chloe Bloom, PhD – Imperial College London ### 2325345###Co-Author######Imperial College London###Co-Author: Chloe Bloom, PhD – Imperial College London
###Presenting Author: Jonathan Fix, PhD, MSPH (he/him/his) – Novavax
### he/him/his @@@ Nadja A. Vielot, PhD, MSPH (she/her/hers) – University of North Carolina at Chapel Hill ### 2325179### Co-Author###Assistant Professor###University of North Carolina at Chapel Hill###Co-Author: Nadja A. Vielot, PhD, MSPH (she/her/hers) – University of North Carolina at Chapel Hill
### she/her/hers @@@ Michele Jonsson Funk, PhD, FISPE (she/her/hers) – University of North Carolina at Chapel Hill ### 1046824###Co-Author###Associate Professor###University of North Carolina at Chapel Hill###Co-Author: Michele Jonsson Funk, PhD, FISPE (she/her/hers) – University of North Carolina at Chapel Hill
### she/her/hers @@@ Til Stürmer, MD, PhD (he/him/his) – University of North Carolina at Chapel Hill ### 1062525###Co-Author###Professor###University of North Carolina at Chapel Hill###Co-Author: Til Stürmer, MD, PhD (he/him/his) – University of North Carolina at Chapel Hill
### he/him/his @@@ David Weber – University of North Carolina at Chapel Hill ### 2325181###Co-Author######University of North Carolina at Chapel Hill###Co-Author: David Weber – University of North Carolina at Chapel Hill
### @@@ Sylvia Becker-Dreps – University of North Carolina at Chapel Hill ### 2325180###Co-Author######University of North Carolina at Chapel Hill###Co-Author: Sylvia Becker-Dreps – University of North Carolina at Chapel Hill
### @@@ Jennifer L. Lund, MSPH, PhD, FISPE (she/her/hers) – University of North Carolina at Chapel Hill ### 1062592###Co-Author###Associate Professor, Department of Epidemiology###University of North Carolina at Chapel Hill###Co-Author: Jennifer L. Lund, MSPH, PhD, FISPE (she/her/hers) – University of North Carolina at Chapel Hill
### she/her/hersPresenting Author: J. Bradley Layton, PhD, FISPE (he/him/his) – RTI Health Solutions
### he/him/his @@@ Lauren S. Peetluk, PhD, MPH (she/her/hers) – Optum Epidemiology ### 1991129###Co-Author###Epidemiologist###Optum Epidemiology###Co-Author: Lauren S. Peetluk, PhD, MPH (she/her/hers) – Optum Epidemiology
### she/her/hers @@@ Patricia C. Lloyd, ScM, PhD – U.S Food and Drug Administration ### 1655306###Co-Author###Health Statistician###U.S Food and Drug Administration###Co-Author: Patricia C. Lloyd, ScM, PhD – U.S Food and Drug Administration
### @@@ Yixin Jiao – Acumen, LLC ### 1991146###Co-Author######Acumen, LLC###Co-Author: Yixin Jiao – Acumen, LLC
### @@@ Djeneba Audrey Djibo, PhD (she/her/hers) – CVS Health ### 1655293###Co-Author###Lead Director -Epidemiology, Safety Surveillance & Collaboration###CVS Health###Co-Author: Djeneba Audrey Djibo, PhD (she/her/hers) – CVS Health
### she/her/hers @@@ Jie Deng – Optum Epidemiology ### 1991126###Co-Author######Optum Epidemiology###Co-Author: Jie Deng – Optum Epidemiology
### @@@ Joann F. Gruber, PhD, MSPH – US FDA ### 1991147###Co-Author###Epidemiologist###US FDA###Co-Author: Joann F. Gruber, PhD, MSPH – US FDA
### @@@ Rachel P. Ogilvie, PhD, MPH – Optum Epidemiology ### 1358090###Co-Author###Senior Epidemiologist###Optum Epidemiology###Co-Author: Rachel P. Ogilvie, PhD, MPH – Optum Epidemiology
### @@@ Ron J. Parambi, MBBS, MPH – Optum ### 1991121###Co-Author###Senior Epidemiology Analyst###Optum###Co-Author: Ron J. Parambi, MBBS, MPH – Optum
### @@@ Michael Miller, n/a – Optum Life Sciences ### 1659009###Co-Author###Epidemiological Data AAnalyst###Optum Life Sciences###Co-Author: Michael Miller, n/a – Optum Life Sciences
### @@@ Jennifer Song, MA, MURP – United Health Group ### 1360471###Co-Author###Senior Epidemiology Analyst###United Health Group###Co-Author: Jennifer Song, MA, MURP – United Health Group
### @@@ Lisa B. Weatherby – Optum Epidemiology ### 1991128###Co-Author######Optum Epidemiology###Co-Author: Lisa B. Weatherby – Optum Epidemiology
### @@@ Elizabeth J. Bell, PhD, MPH (she/her/hers) – Harvard Pilgrim Health Care Institute ### 1659086###Co-Author###Senior Research Scientist###Harvard Pilgrim Health Care Institute###Co-Author: Elizabeth J. Bell, PhD, MPH (she/her/hers) – Harvard Pilgrim Health Care Institute
### she/her/hers @@@ An-Chi Lo – Acumen, LLC ### 1358511###Co-Author######Acumen, LLC###Co-Author: An-Chi Lo – Acumen, LLC
### @@@ Jessica R. Hervol, MPH – Acumen, LLC ### 2325148###Co-Author######Acumen, LLC###Co-Author: Jessica R. Hervol, MPH – Acumen, LLC
### @@@ Michael Wernecke, BA (he/him/his) – Acumen, LLC ### 1358529###Co-Author###Senior Research Manager###Acumen, LLC###Co-Author: Michael Wernecke, BA (he/him/his) – Acumen, LLC
### he/him/his @@@ Sylvia Cho, PhD – US FDA ### 2325116###Co-Author######US FDA###Co-Author: Sylvia Cho, PhD – US FDA
### @@@ Hui-Lee Wong, PhD (she/her/hers) – US Food and Drug Administration ### 1358856###Co-Author###Associate Director for Science###US Food and Drug Administration###Co-Author: Hui-Lee Wong, PhD (she/her/hers) – US Food and Drug Administration
### she/her/hers @@@ Tainya C. Clarke, PhD, MPH, MSc (she/her/hers) – US FDA ### 1655307###Co-Author###Epidemiologist/Health Statistician###US FDA###Co-Author: Tainya C. Clarke, PhD, MPH, MSc (she/her/hers) – US FDA
### she/her/hers @@@ Christine L. Bui, MPH – RTI-HS ### 2325149###Co-Author###Director, Epidemiology###RTI-HS###Co-Author: Christine L. Bui, MPH – RTI-HS
### @@@ Alexandra Stone, PhD, MSc – Optum Serve ### 1991303###Co-Author###Managing Consultant###Optum Serve###Co-Author: Alexandra Stone, PhD, MSc – Optum Serve
### @@@ Wafa Tarazi, PhD, MHPA – Optum Serve ### 1991285###Co-Author###Senior Consultant/ Epidemiologist###Optum Serve###Co-Author: Wafa Tarazi, PhD, MHPA – Optum Serve
### @@@ Jonathan Deshazo, PhD, MPH – CVS Health ### 2325150###Co-Author######CVS Health###Co-Author: Jonathan Deshazo, PhD, MPH – CVS Health
### @@@ Richard A. Forshee, PhD – Office of Biostatistics and Pharmacovigilance, CBER, US FDA ### 1358508###Co-Author###Deputy Director###Office of Biostatistics and Pharmacovigilance, CBER, US FDA###Co-Author: Richard A. Forshee, PhD – Office of Biostatistics and Pharmacovigilance, CBER, US FDA
### @@@ Steven A. Anderson, PhD, MPP – Food and Drug Administration ### 1358532###Co-Author######Food and Drug Administration###Co-Author: Steven A. Anderson, PhD, MPP – Food and Drug Administration
### @@@ John D. Seeger, PharmD, DrPH, FISPE – Harvard T.H. Chan School of Public Health ### 1046832###Co-Author###Adjunct Faculty###Harvard T.H. Chan School of Public Health###Co-Author: John D. Seeger, PharmD, DrPH, FISPE – Harvard T.H. Chan School of Public Health
### @@@ Kandace L. Amend, PhD – Optum Epidemiology ### 1063027###Co-Author###Senior Epidemiologist###Optum Epidemiology###Co-Author: Kandace L. Amend, PhD – Optum Epidemiology
### @@@ Cheryl N. McMahill-Walraven, MSW, PhD – CVS Health ### 1358102###Co-Author###Executive Director-Safety Surveillance & Collaboration###CVS Health###Co-Author: Cheryl N. McMahill-Walraven, MSW, PhD – CVS Health
### @@@ Yoganand Chillarige, MPA – Acumen LLC ### 1655508###Co-Author###Research Manager###Acumen LLC###Co-Author: Yoganand Chillarige, MPA – Acumen LLC
### @@@ Grace W. Yang – OptumServe ### 1659346###Co-Author######OptumServe###Co-Author: Grace W. Yang – OptumServe
### @@@ Mary S. Anthony, PhD – RTI International Health Solutions ### 1095302###Co-Author###Senior Director, Epidemiology###RTI International Health Solutions###Co-Author: Mary S. Anthony, PhD – RTI International Health Solutions
### @@@ Azadeh Shoaibi, PhD, MHS – FDA ### 1358855###Co-Author###Associate Director Post-market Surveillance###FDA###Co-Author: Azadeh Shoaibi, PhD, MHS – FDA
###Moderator: Priya Bahri, PhD – European Medicines Agency (EMA)
### @@@ Caitlin Knox, PhD MPH FISPE (she/her/hers) – Regeneron Pharmaceuticals ### 1360272###Moderator###Sr Dir, Pharmacoepidemiology###Regeneron Pharmaceuticals###Moderator: Caitlin Knox, PhD MPH FISPE (she/her/hers) – Regeneron Pharmaceuticals
### she/her/hersPresenting Author: Hwa Yeon Ko, PharmD – School of Pharmacy, Sungkyunkwan University, Suwon, South Korea
### @@@ Sohee Park, PharmD, PhD (she/her/hers) – Aston Pharmacy School ### 2327663###Co-Author###Lecturer###Aston Pharmacy School###Co-Author: Sohee Park, PharmD, PhD (she/her/hers) – Aston Pharmacy School
### she/her/hers @@@ Ahhyung Choi, PharmD, PhD – School of Pharmacy, Sungkyunkwan University, Suwon, Korea ### 1358469###Co-Author###PhD Student###School of Pharmacy, Sungkyunkwan University, Suwon, Korea###Co-Author: Ahhyung Choi, PharmD, PhD – School of Pharmacy, Sungkyunkwan University, Suwon, Korea
### @@@ Han Eol Jeong, MPH, PhD – School of Pharmacy, Sungkyunkwan University, Suwon, South Korea ### 2329936###Co-Author######School of Pharmacy, Sungkyunkwan University, Suwon, South Korea###Co-Author: Han Eol Jeong, MPH, PhD – School of Pharmacy, Sungkyunkwan University, Suwon, South Korea
### @@@ Brian Meng-Hsun Li, MClinPharm – Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Taiwan ### 2325378###Co-Author###PhD student###Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Taiwan###Co-Author: Brian Meng-Hsun Li, MClinPharm – Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Taiwan
### @@@ Michael Chun-Yuan Cheng, MA (he/him/his) – Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Tainan, Taiwan ### 1994356###Co-Author###Research Associate###Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Tainan, Taiwan###Co-Author: Michael Chun-Yuan Cheng, MA (he/him/his) – Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Tainan, Taiwan
### he/him/his @@@ Miyuki Hsing-Chun Hsieh, PhD – Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Tainan, Taiwan ### 1062943###Co-Author###Immediate Past Chair of the ISPE Student Council###Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Tainan, Taiwan###Co-Author: Miyuki Hsing-Chun Hsieh, PhD – Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Tainan, Taiwan
### @@@ Philip C.M. Au, MPhil – Centre for Safe Medication Practice and Research, Department of Pharmacology and Pharmacy, University of Hong Kong, Hong Kong ### 2331006###Co-Author######Centre for Safe Medication Practice and Research, Department of Pharmacology and Pharmacy, University of Hong Kong, Hong Kong###Co-Author: Philip C.M. Au, MPhil – Centre for Safe Medication Practice and Research, Department of Pharmacology and Pharmacy, University of Hong Kong, Hong Kong
### @@@ Ching Lung Cheung, PhD – Department of Pharmacology and Pharmacy, Li Ka Shing Faculty of Medicine, The University of Hong Kong ### 2330869###Co-Author######Department of Pharmacology and Pharmacy, Li Ka Shing Faculty of Medicine, The University of Hong Kong###Co-Author: Ching Lung Cheung, PhD – Department of Pharmacology and Pharmacy, Li Ka Shing Faculty of Medicine, The University of Hong Kong
### @@@ Edward Chia-Cheng Lai, PhD (he/him/his) – Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Taiwan ### 1358157###Co-Author###Professor###Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Taiwan###Co-Author: Edward Chia-Cheng Lai, PhD (he/him/his) – Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Taiwan
### he/him/his @@@ Kenneth KC Man, PhD, CStat, FRSPH (he/him/his) – UCL School of Pharmacy ### 1358158###Co-Author###Lecturer/Assistant Professor###UCL School of Pharmacy###Co-Author: Kenneth KC Man, PhD, CStat, FRSPH (he/him/his) – UCL School of Pharmacy
### he/him/his @@@ Ian Chi Kei Wong, PhD (he/him/his) – Centre for Safe Medication Practice and research, Department of Pharmacology and Pharmacy, Li Ka Shing Faculty of Medicine, The University of Hong Kong ### 1358232###Co-Author###Professor###Centre for Safe Medication Practice and research, Department of Pharmacology and Pharmacy, Li Ka Shing Faculty of Medicine, The University of Hong Kong###Co-Author: Ian Chi Kei Wong, PhD (he/him/his) – Centre for Safe Medication Practice and research, Department of Pharmacology and Pharmacy, Li Ka Shing Faculty of Medicine, The University of Hong Kong
### he/him/his @@@ Ju-Young Shin, PhD – School of Pharmacy, Sungkyunkwan University, Suwon, South Korea ### 1302813###Co-Author###Associate Professor###School of Pharmacy, Sungkyunkwan University, Suwon, South Korea###Co-Author: Ju-Young Shin, PhD – School of Pharmacy, Sungkyunkwan University, Suwon, South Korea
###Presenting Author: Géric Maura, PhD – Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden
### @@@ Pierre-Olivier Blotière – Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden ### 1660114###Co-Author###PhD###Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden###Co-Author: Pierre-Olivier Blotière – Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden
### @@@ Edouard L. Fu – Leiden University Medical Center ### 2325333###Co-Author######Leiden University Medical Center###Co-Author: Edouard L. Fu – Leiden University Medical Center
### @@@ Juan J. Carrero – Department of Medical Epidemiology and Biostatistics, Karolinska Institutet ### 1397864###Co-Author######Department of Medical Epidemiology and Biostatistics, Karolinska Institutet###Co-Author: Juan J. Carrero – Department of Medical Epidemiology and Biostatistics, Karolinska Institutet
###Presenting Author: Thomas Cars – Sence Research BV
### @@@ Stefan Gustafsson – Sence Research BV ### 2325144###Co-Author######Sence Research BV###Co-Author: Stefan Gustafsson – Sence Research BV
### @@@ Queenie Chan, MEng, MSc, PhD – Center for Observational Research, Amgen Ltd ### 2325141###Co-Author###Observational Research Senior Manager###Center for Observational Research, Amgen Ltd###Co-Author: Queenie Chan, MEng, MSc, PhD – Center for Observational Research, Amgen Ltd
### @@@ Nafeesa Dhalwani – Center for Observational Research, Amgen Inc ### 2325142###Co-Author######Center for Observational Research, Amgen Inc###Co-Author: Nafeesa Dhalwani – Center for Observational Research, Amgen Inc
### @@@ Shia T. Kent, PhD – Center for Observational Research, Amgen Inc ### 1991702###Co-Author###Observational Research Senior Manager###Center for Observational Research, Amgen Inc###Co-Author: Shia T. Kent, PhD – Center for Observational Research, Amgen Inc
### @@@ Johan Sundstrom – Department of Medical Sciences, Uppsala University ### 2325484###Co-Author######Department of Medical Sciences, Uppsala University###Co-Author: Johan Sundstrom – Department of Medical Sciences, Uppsala University
### @@@ Emil Hagstrom – Uppsala Clinical Research Center ### 2325145###Co-Author######Uppsala Clinical Research Center###Co-Author: Emil Hagstrom – Uppsala Clinical Research Center
### @@@ M. Alan Brookhart, PhD – Target RWE ### 1991706###Co-Author###Professor###Target RWE###Co-Author: M. Alan Brookhart, PhD – Target RWE
###Presenting Author: Tania Schink, Dr, MPH (she/her/hers) – Leibniz Institute for Prevention Research and Epidemiology - BIPS
### she/her/hers @@@ Bianca Kollhorst, PhD (she/her/hers) – Leibniz Institute for Prevention Research and Epidemiology - BIPS ### 1397900###Co-Author###Statistician, postdoctoral research fellow###Leibniz Institute for Prevention Research and Epidemiology - BIPS###Co-Author: Bianca Kollhorst, PhD (she/her/hers) – Leibniz Institute for Prevention Research and Epidemiology - BIPS
### she/her/hers @@@ Ulrike Haug, PhD – Leibniz Institute for Prevention Research and Epidemiology - BIPS ### 1062658###Co-Author###Prof. Dr. sc. hum.###Leibniz Institute for Prevention Research and Epidemiology - BIPS###Co-Author: Ulrike Haug, PhD – Leibniz Institute for Prevention Research and Epidemiology - BIPS
###Presenting Author: Mingfeng Zhang, MD, PhD – Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, Food and Drug Administration
### @@@ Dan Li – Division of Bioinformatics and Biostatistics, National Center for Toxicological Research, U.S. Food and Drug Administration ### 2325425###Co-Author###Bioinformatician###Division of Bioinformatics and Biostatistics, National Center for Toxicological Research, U.S. Food and Drug Administration###Co-Author: Dan Li – Division of Bioinformatics and Biostatistics, National Center for Toxicological Research, U.S. Food and Drug Administration
### @@@ Leihong Wu – Division of Bioinformatics and Biostatistics, National Center for Toxicological Research, U.S. Food and Drug Administration ### 2325426###Co-Author###Bioinformatician###Division of Bioinformatics and Biostatistics, National Center for Toxicological Research, U.S. Food and Drug Administration###Co-Author: Leihong Wu – Division of Bioinformatics and Biostatistics, National Center for Toxicological Research, U.S. Food and Drug Administration
### @@@ Robert Ball, MD, MPH, ScM – Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, Food and Drug Administration ### 1359919###Co-Author###Deputy Super Office Director###Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, Food and Drug Administration###Co-Author: Robert Ball, MD, MPH, ScM – Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, Food and Drug Administration
### @@@ Joshua Xu – Division of Bioinformatics and Biostatistics, National Center for Toxicological Research, U.S. Food and Drug Administration ### 2325427###Co-Author###Supervisory Computer Scientist###Division of Bioinformatics and Biostatistics, National Center for Toxicological Research, U.S. Food and Drug Administration###Co-Author: Joshua Xu – Division of Bioinformatics and Biostatistics, National Center for Toxicological Research, U.S. Food and Drug Administration
###Presenting Author: G. Caleb Alexander, MD – Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD
### @@@ Jill Curran – Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland ### 2325468###Co-Author######Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland###Co-Author: Jill Curran – Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland
### @@@ Alejandro Victores – Merck & Co., Inc., Rahway, New Jersey, US ### 2325565###Co-Author######Merck & Co., Inc., Rahway, New Jersey, US###Co-Author: Alejandro Victores – Merck & Co., Inc., Rahway, New Jersey, US
### @@@ Hemalkumar B. Mehta, MS, PhD (he/him/his) – Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health ### 1093588###Co-Author###Associate Professor###Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health###Co-Author: Hemalkumar B. Mehta, MS, PhD (he/him/his) – Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health
### he/him/his @@@ Shanshan Lin, ScM – Johns Hopkins University, School of Medicine, Division of General Internal of Medicine ### 1992291###Co-Author###Research data analyst###Johns Hopkins University, School of Medicine, Division of General Internal of Medicine###Co-Author: Shanshan Lin, ScM – Johns Hopkins University, School of Medicine, Division of General Internal of Medicine
### @@@ Xuya Xiao, MHS (she/her/hers) – Johns Hopkins Bloomberg School of Public Health ### 1991149###Co-Author###Research analyst###Johns Hopkins Bloomberg School of Public Health###Co-Author: Xuya Xiao, MHS (she/her/hers) – Johns Hopkins Bloomberg School of Public Health
### she/her/hers @@@ Erin D. Michos – Division of Cardiology, Johns Hopkins Medicine, Baltimore, Maryland ### 2325566###Co-Author######Division of Cardiology, Johns Hopkins Medicine, Baltimore, Maryland###Co-Author: Erin D. Michos – Division of Cardiology, Johns Hopkins Medicine, Baltimore, Maryland
### @@@ Jeromie Ballreich – Department of Health Policy and Management, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland ### 1359926###Co-Author###Assistant Scientist###Department of Health Policy and Management, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland###Co-Author: Jeromie Ballreich – Department of Health Policy and Management, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland
### @@@ Lori D. Bash – Merck & Co., Inc., Rahway, New Jersey, US ### 2325567###Co-Author######Merck & Co., Inc., Rahway, New Jersey, US###Co-Author: Lori D. Bash – Merck & Co., Inc., Rahway, New Jersey, US
### @@@ Jason Exter – Merck & Co., Inc., Rahway, New Jersey, US ### 2325568###Co-Author######Merck & Co., Inc., Rahway, New Jersey, US###Co-Author: Jason Exter – Merck & Co., Inc., Rahway, New Jersey, US
### @@@ Seth S. Martin – Division of Cardiology, Johns Hopkins Medicine, Baltimore, Maryland ### 2325569###Co-Author######Division of Cardiology, Johns Hopkins Medicine, Baltimore, Maryland###Co-Author: Seth S. Martin – Division of Cardiology, Johns Hopkins Medicine, Baltimore, Maryland
### @@@ Kathryn Foti – Department of Epidemiology, University of Alabama at Birmingham School of Public Health, Birmingham, Alabama ### 2325570###Co-Author######Department of Epidemiology, University of Alabama at Birmingham School of Public Health, Birmingham, Alabama###Co-Author: Kathryn Foti – Department of Epidemiology, University of Alabama at Birmingham School of Public Health, Birmingham, Alabama
###Lead Speaker: Mary E. Ritchey, PhD, FISPE – CERobs Consulting
### @@@ Paul Coplan – MedTech Epidemiology & Real-World Data Sciences, Johnson & Johnson ### 2326930###Speaker######MedTech Epidemiology & Real-World Data Sciences, Johnson & Johnson###Speaker: Paul Coplan – MedTech Epidemiology & Real-World Data Sciences, Johnson & Johnson
### @@@ Mackenzie Herzog, PhD, MPH – IQVIA ### 2330847###Speaker###Director, Epidemiology###IQVIA###Speaker: Mackenzie Herzog, PhD, MPH – IQVIA
### @@@ Stephen S. Johnston, PhD – Johnson and Johnson ### 1657997###Speaker###Senior Director###Johnson and Johnson###Speaker: Stephen S. Johnston, PhD – Johnson and Johnson
### @@@ David Maislin – Biomedical Statistical Consulting ### 1761991###Speaker###Managing Partner###Biomedical Statistical Consulting###Speaker: David Maislin – Biomedical Statistical Consulting
### @@@ Lisa Weiss, PhD – Healthcare Innovation & Technology Lab ### 1088159###Speaker######Healthcare Innovation & Technology Lab###Speaker: Lisa Weiss, PhD – Healthcare Innovation & Technology Lab
###Presenting Author: Chun-Ting Yang, PhD – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School
### @@@ Kerry Ngan – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA ### 2325347###Co-Author######Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA###Co-Author: Kerry Ngan – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA
### @@@ Dae Hyun Kim, MD, ScD – Hebrew SeniorLife Marcus Institute for Aging Research ### 1655334###Co-Author###Associate Professor of Medicine, Harvard Medical School###Hebrew SeniorLife Marcus Institute for Aging Research###Co-Author: Dae Hyun Kim, MD, ScD – Hebrew SeniorLife Marcus Institute for Aging Research
### @@@ Jun Liu – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School ### 1659307###Co-Author######Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School###Co-Author: Jun Liu – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School
### @@@ Kueiyu Joshua Lin, MD, ScD – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School ### 1082840###Co-Author###Assistant Professor###Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School###Co-Author: Kueiyu Joshua Lin, MD, ScD – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School
###Lead Speaker: Michele Jonsson Funk, PhD, FISPE (she/her/hers) – University of North Carolina at Chapel Hill
### she/her/hers @@@ Andrew WJ Toler, MS – Axle Informatics ### 2325715###Speaker###Assistant Director, Real World Evidence###Axle Informatics###Speaker: Andrew WJ Toler, MS – Axle Informatics
###Presenting Author: Jocelyn Buisker, MSc – Novartis Pharma AG, Basel, Switzerland
### @@@ Sigrid Behr, PhD – Novartis Pharma AG ### 2330987###Co-Author######Novartis Pharma AG###Co-Author: Sigrid Behr, PhD – Novartis Pharma AG
###Presenting Author: Christopher Bush, MPH (he/him/his) – Aetion, Inc.
### he/him/his @@@ Neloufar Rahai, PhD, MPH (she/her/hers) – Aetion, Inc. ### 1991443###Co-Author###Senior Scientist###Aetion, Inc.###Co-Author: Neloufar Rahai, PhD, MPH (she/her/hers) – Aetion, Inc.
### she/her/hers @@@ John Kroner – Aetion, Inc. ### 2325311###Co-Author######Aetion, Inc.###Co-Author: John Kroner – Aetion, Inc.
### @@@ Brian Conroy – Aetion, Inc. ### 2325310###Co-Author######Aetion, Inc.###Co-Author: Brian Conroy – Aetion, Inc.
### @@@ Katherine E. Mues, PhD, MPH – Aetion, Inc. ### 1655854###Co-Author###Vice President###Aetion, Inc.###Co-Author: Katherine E. Mues, PhD, MPH – Aetion, Inc.
### @@@ Priyadarshani Dharia, PhD, MD, MPH (she/her/hers) – Moderna, Inc. ### 1655853###Co-Author###Director, Global Safety Epidemiologist###Moderna, Inc.###Co-Author: Priyadarshani Dharia, PhD, MD, MPH (she/her/hers) – Moderna, Inc.
### she/her/hers @@@ Lei Zhu – Moderna, Inc. ### 1993192###Co-Author######Moderna, Inc.###Co-Author: Lei Zhu – Moderna, Inc.
### @@@ Daina B. Esposito, MPH, PhD (she/her/hers) – Moderna, Inc. ### 1655290###Co-Author###Sr. Director, Global Safety Epidemiologist###Moderna, Inc.###Co-Author: Daina B. Esposito, MPH, PhD (she/her/hers) – Moderna, Inc.
### she/her/hersPresenting Author: Phyo T. Htoo, MD, PhD – Brigham and Women's Hospital and Harvard Medical School
### @@@ Elisabetta Patorno, MD, DrPH (she/her/hers) – Brigham and Women's Hospital and ### 1360380###Co-Author###Associate Professor of Medicine###Brigham and Women's Hospital and###Co-Author: Elisabetta Patorno, MD, DrPH (she/her/hers) – Brigham and Women's Hospital and
### she/her/hers @@@ Sebastian Schneeweiss, MD, ScD (he/him/his) – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School ### 1046819###Co-Author###Professor of Medicine###Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School###Co-Author: Sebastian Schneeweiss, MD, ScD (he/him/his) – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School
### he/him/his @@@ Shirley V. Wang, PhD (she/her/hers) – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School ### 1062580###Co-Author###Associate Professor###Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School###Co-Author: Shirley V. Wang, PhD (she/her/hers) – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School
### she/her/hersPresenting Author: Chin-Yao Shen, MClinPharm – School of Pharmacy, Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Tainan, Taiwan
### @@@ Albert Tzu-Ming Chuang, PharmD – National Cheng Kung University ### 1991536###Co-Author###Research fellow###National Cheng Kung University###Co-Author: Albert Tzu-Ming Chuang, PharmD – National Cheng Kung University
### @@@ Daniel Hsiang-Te Tsai, MClinPharm – School of Pharmacy, Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Tainan, Taiwan ### 1658474###Co-Author###PhD student###School of Pharmacy, Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Tainan, Taiwan###Co-Author: Daniel Hsiang-Te Tsai, MClinPharm – School of Pharmacy, Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Tainan, Taiwan
### @@@ Edward Chia-Cheng Lai, PhD (he/him/his) – Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Taiwan ### 1358157###Co-Author###Professor###Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Taiwan###Co-Author: Edward Chia-Cheng Lai, PhD (he/him/his) – Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Taiwan
### he/him/hisPresenting Author: Elizabeth M. Garry, PhD, MPH (she/her/hers) – Aetion, Inc.
### she/her/hers @@@ Aidan Baglivo, BS – Aetion ### 1655637###Co-Author###Senior Analyst###Aetion###Co-Author: Aidan Baglivo, BS – Aetion
### @@@ Priya Govil, BA – Aetion ### 1655431###Co-Author###Senior Analyst###Aetion###Co-Author: Priya Govil, BA – Aetion
### @@@ Jennifer L. Duryea, MPH – Replica Analytics ### 2325660###Co-Author###Lead Product Manager###Replica Analytics###Co-Author: Jennifer L. Duryea, MPH – Replica Analytics
### @@@ Ayad K. Ali, RPh, PhD, FACE – Aetion, Inc ### 1657558###Co-Author###Principal Pharmacoepidemiologist###Aetion, Inc###Co-Author: Ayad K. Ali, RPh, PhD, FACE – Aetion, Inc
### @@@ Wei Liu, PhD, MSc – Office of Surveillance and Epidemiology, US Food and Drug Administration ### 1358274###Co-Author######Office of Surveillance and Epidemiology, US Food and Drug Administration###Co-Author: Wei Liu, PhD, MSc – Office of Surveillance and Epidemiology, US Food and Drug Administration
### @@@ Tamar Lasky, PhD (she/her/hers) – Retired ### 2325357###Co-Author###Retired###Retired###Co-Author: Tamar Lasky, PhD (she/her/hers) – Retired
### she/her/hers @@@ Aloka Chakravarty, PhD, Mstat – Pfizer, Inc. ### 2325528###Co-Author###VP, Head of Enterprise RWE###Pfizer, Inc.###Co-Author: Aloka Chakravarty, PhD, Mstat – Pfizer, Inc.
### @@@ Marie C. Bradley, PhD, MPharm, MSc.PH – Real World Evidence Analytics, Office of Medical Policy, CDER, US FDA ### 1062817###Co-Author###Senior Advisor###Real World Evidence Analytics, Office of Medical Policy, CDER, US FDA###Co-Author: Marie C. Bradley, PhD, MPharm, MSc.PH – Real World Evidence Analytics, Office of Medical Policy, CDER, US FDA
###Lead Speaker: Shahab Abtahi, MD, PhD – Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University
### @@@ Rosa Gini, PhD (she/her/hers) – ARS Toscana, Florence, Italy ### 1302758###Speaker###Head of Unit at ARS Toscana, Florence, Italy###ARS Toscana, Florence, Italy###Speaker: Rosa Gini, PhD (she/her/hers) – ARS Toscana, Florence, Italy
### she/her/hers @@@ Miriam C.J.M. Sturkenboom, PhD – Department of Data Science & Biostatistics, Julius Global Health, University Medical Center Utrecht (UMCU), Utrecht, the Netherlands ### 1359696###Speaker###Professor###Department of Data Science & Biostatistics, Julius Global Health, University Medical Center Utrecht (UMCU), Utrecht, the Netherlands###Speaker: Miriam C.J.M. Sturkenboom, PhD – Department of Data Science & Biostatistics, Julius Global Health, University Medical Center Utrecht (UMCU), Utrecht, the Netherlands
### @@@ Vjola Hoxhaj, PharmD, MSc (she/her/hers) – Julius Center for Health Science and Primary Care, University Medical Center Utrecht, the Netherlands ### 1991500###Speaker###Scientific Programmer & PhD Student###Julius Center for Health Science and Primary Care, University Medical Center Utrecht, the Netherlands###Speaker: Vjola Hoxhaj, PharmD, MSc (she/her/hers) – Julius Center for Health Science and Primary Care, University Medical Center Utrecht, the Netherlands
### she/her/hers @@@ Daniel R. Morales, PhD – European Medicines Agency ### 1062632###Speaker###pharmacoepidemiologist###European Medicines Agency###Speaker: Daniel R. Morales, PhD – European Medicines Agency
### @@@ Donna R. Rivera, PharmD, MSc – Oncology Center of Excellence, U.S. Food and Drug Administration ### 1358504###Speaker###Associate Director of Pharmacoepidemiology###Oncology Center of Excellence, U.S. Food and Drug Administration###Speaker: Donna R. Rivera, PharmD, MSc – Oncology Center of Excellence, U.S. Food and Drug Administration
### @@@ Kenneth KC Man, PhD, CStat, FRSPH (he/him/his) – UCL School of Pharmacy ### 1358158###Speaker###Lecturer/Assistant Professor###UCL School of Pharmacy###Speaker: Kenneth KC Man, PhD, CStat, FRSPH (he/him/his) – UCL School of Pharmacy
### he/him/his @@@ Jeffrey Brown, PhD – TriNetX ### 1655343###Speaker###Chief Scientific Officer###TriNetX###Speaker: Jeffrey Brown, PhD – TriNetX
### @@@ Olaf H. Klungel, PharmD, PhD – Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University ### 1062523###Speaker###Head of Division###Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University###Speaker: Olaf H. Klungel, PharmD, PhD – Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University
### @@@ Judit Riera-Arnau, MD – Department of Data Science and Biostatistics, Julius Global Health, University Medical Center Utrecht (UMCU), Utrecht, Netherlands ### 1991418###Speaker###PhD candidate###Department of Data Science and Biostatistics, Julius Global Health, University Medical Center Utrecht (UMCU), Utrecht, Netherlands###Speaker: Judit Riera-Arnau, MD – Department of Data Science and Biostatistics, Julius Global Health, University Medical Center Utrecht (UMCU), Utrecht, Netherlands
### @@@ Constanza L. L. Andaur Navarro, PhD – Julius Center for Health Science and Primary Care, University Medical Center Utrecht, the Netherlands ### 1991498###Speaker###Assistant Professor###Julius Center for Health Science and Primary Care, University Medical Center Utrecht, the Netherlands###Speaker: Constanza L. L. Andaur Navarro, PhD – Julius Center for Health Science and Primary Care, University Medical Center Utrecht, the Netherlands
### @@@ Anton Pottegård, PhD, DMSc – University of Southern Denmark ### 1062518###Speaker###Professor###University of Southern Denmark###Speaker: Anton Pottegård, PhD, DMSc – University of Southern Denmark
### @@@ Robert W. Platt, PhD (he/him/his) – McGill University ### 1358167###Speaker###Professor###McGill University###Speaker: Robert W. Platt, PhD (he/him/his) – McGill University
### he/him/hisPresenting Author: Richard A. Forshee, PhD – Office of Biostatistics and Pharmacovigilance, CBER, US FDA
### @@@ Elizabeth R. Smith – Acumen, LLC ### 1659094###Co-Author######Acumen, LLC###Co-Author: Elizabeth R. Smith – Acumen, LLC
### @@@ Zhiruo Wan, MS – Acumen LLC ### 1993607###Co-Author###Data and Policy Analyst IV###Acumen LLC###Co-Author: Zhiruo Wan, MS – Acumen LLC
### @@@ Kandace L. Amend, PhD – Optum Epidemiology ### 1063027###Co-Author###Senior Epidemiologist###Optum Epidemiology###Co-Author: Kandace L. Amend, PhD – Optum Epidemiology
### @@@ Alex Secora, PhD – IQVIA ### 1991253###Co-Author###Asociate Director of Epidemiology###IQVIA###Co-Author: Alex Secora, PhD – IQVIA
### @@@ Djeneba Audrey Djibo, PhD (she/her/hers) – CVS Health ### 1655293###Co-Author###Lead Director -Epidemiology, Safety Surveillance & Collaboration###CVS Health###Co-Author: Djeneba Audrey Djibo, PhD (she/her/hers) – CVS Health
### she/her/hers @@@ Kamran Kazemi – Acumen, LLC ### 2325466###Co-Author######Acumen, LLC###Co-Author: Kamran Kazemi – Acumen, LLC
### @@@ Jennifer Song, MA, MURP – United Health Group ### 1360471###Co-Author###Senior Epidemiology Analyst###United Health Group###Co-Author: Jennifer Song, MA, MURP – United Health Group
### @@@ Lauren E. Parlett, PhD (she/her/hers) – Carelon Research, Inc ### 2325147###Co-Author###Senior Research Scientist###Carelon Research, Inc###Co-Author: Lauren E. Parlett, PhD (she/her/hers) – Carelon Research, Inc
### she/her/hers @@@ Jonathan Deshazo, PhD, MPH – CVS Health ### 2325150###Co-Author######CVS Health###Co-Author: Jonathan Deshazo, PhD, MPH – CVS Health
### @@@ John D. Seeger, PharmD, DrPH, FISPE – Harvard T.H. Chan School of Public Health ### 1046832###Co-Author###Adjunct Faculty###Harvard T.H. Chan School of Public Health###Co-Author: John D. Seeger, PharmD, DrPH, FISPE – Harvard T.H. Chan School of Public Health
### @@@ Nandini Selvam, PhD, MPH – IQVIA ### 2325467###Co-Author###VP & GM###IQVIA###Co-Author: Nandini Selvam, PhD, MPH – IQVIA
### @@@ Cheryl N. McMahill-Walraven, MSW, PhD – CVS Health ### 1358102###Co-Author###Executive Director-Safety Surveillance & Collaboration###CVS Health###Co-Author: Cheryl N. McMahill-Walraven, MSW, PhD – CVS Health
### @@@ Mao I. Hu, BS – Acumen LLC ### 1655532###Co-Author###Policy Researcher###Acumen LLC###Co-Author: Mao I. Hu, BS – Acumen LLC
### @@@ Yoganand Chillarige, MPA – Acumen LLC ### 1655508###Co-Author###Research Manager###Acumen LLC###Co-Author: Yoganand Chillarige, MPA – Acumen LLC
### @@@ Steven A. Anderson, PhD, MPP – Food and Drug Administration ### 1358532###Co-Author######Food and Drug Administration###Co-Author: Steven A. Anderson, PhD, MPP – Food and Drug Administration
###Presenting Author: J. Bradley Layton, PhD, FISPE (he/him/his) – RTI Health Solutions
### he/him/his @@@ Morgan M. Richey, Ph.D, MPH – RTI International ### 2325231###Co-Author###Research Pharmacoepidemiologist###RTI International###Co-Author: Morgan M. Richey, Ph.D, MPH – RTI International
### @@@ Arnstein Lindaas, MA – Acumen, LLC ### 1991272###Co-Author######Acumen, LLC###Co-Author: Arnstein Lindaas, MA – Acumen, LLC
### @@@ Stella G. Muthuri, PhD – IBM Consulting ### 1660980###Co-Author###Epidemiologist###IBM Consulting###Co-Author: Stella G. Muthuri, PhD – IBM Consulting
### @@@ Patricia C. Lloyd, ScM, PhD – U.S Food and Drug Administration ### 1655306###Co-Author###Health Statistician###U.S Food and Drug Administration###Co-Author: Patricia C. Lloyd, ScM, PhD – U.S Food and Drug Administration
### @@@ Joann F. Gruber, PhD, MSPH – US FDA ### 1991147###Co-Author###Epidemiologist###US FDA###Co-Author: Joann F. Gruber, PhD, MSPH – US FDA
### @@@ Christine L. Bui, MPH – RTI-HS ### 2325149###Co-Author###Director, Epidemiology###RTI-HS###Co-Author: Christine L. Bui, MPH – RTI-HS
### @@@ Mollie McKillop – IBM Consulting ### 2325193###Co-Author######IBM Consulting###Co-Author: Mollie McKillop – IBM Consulting
### @@@ Lisa Kowarski, MPH – IBM Consulting ### 1658849###Co-Author######IBM Consulting###Co-Author: Lisa Kowarski, MPH – IBM Consulting
### @@@ Hai Lyu – Acumen., LLC ### 2325541###Co-Author###Policy Associate###Acumen., LLC###Co-Author: Hai Lyu – Acumen., LLC
### @@@ Angela Cheng, MPH – Acumen LLC ### 2325195###Co-Author######Acumen LLC###Co-Author: Angela Cheng, MPH – Acumen LLC
### @@@ Zhiruo Wan, MS – Acumen LLC ### 1993607###Co-Author###Data and Policy Analyst IV###Acumen LLC###Co-Author: Zhiruo Wan, MS – Acumen LLC
### @@@ Tainya C. Clarke, PhD, MPH, MSc (she/her/hers) – US FDA ### 1655307###Co-Author###Epidemiologist/Health Statistician###US FDA###Co-Author: Tainya C. Clarke, PhD, MPH, MSc (she/her/hers) – US FDA
### she/her/hers @@@ Alison Tse Kawai, ScD, ScM – RTI Health Solutions ### 1095195###Co-Author###Director, Epidemiology###RTI Health Solutions###Co-Author: Alison Tse Kawai, ScD, ScM – RTI Health Solutions
### @@@ Jeffrey B. Beers, MD – IBM Consulting ### 1658850###Co-Author###Clinical SME###IBM Consulting###Co-Author: Jeffrey B. Beers, MD – IBM Consulting
### @@@ Richard A. Forshee, PhD – Office of Biostatistics and Pharmacovigilance, CBER, US FDA ### 1358508###Co-Author###Deputy Director###Office of Biostatistics and Pharmacovigilance, CBER, US FDA###Co-Author: Richard A. Forshee, PhD – Office of Biostatistics and Pharmacovigilance, CBER, US FDA
### @@@ Steven A. Anderson, PhD, MPP – Food and Drug Administration ### 1358532###Co-Author######Food and Drug Administration###Co-Author: Steven A. Anderson, PhD, MPP – Food and Drug Administration
### @@@ Timothy Burrell, MD, MBA – IBM Consulting ### 1658852###Co-Author###Associate Partner###IBM Consulting###Co-Author: Timothy Burrell, MD, MBA – IBM Consulting
### @@@ Yoganand Chillarige, MPA – Acumen LLC ### 1655508###Co-Author###Research Manager###Acumen LLC###Co-Author: Yoganand Chillarige, MPA – Acumen LLC
### @@@ Mary S. Anthony, PhD – RTI International Health Solutions ### 1095302###Co-Author###Senior Director, Epidemiology###RTI International Health Solutions###Co-Author: Mary S. Anthony, PhD – RTI International Health Solutions
### @@@ Azadeh Shoaibi, PhD, MHS – FDA ### 1358855###Co-Author###Associate Director Post-market Surveillance###FDA###Co-Author: Azadeh Shoaibi, PhD, MHS – FDA
###Presenting Author: Lorraine PONCET, PhD – EPI-PHARE, French National Agency for Medicines and Health Products Safety (ANSM) and French National Health Insurance (CNAM)
### @@@ Noémie Roland, PhD – EPI-PHARE ### 2327346###Co-Author###Epidemiologist###EPI-PHARE###Co-Author: Noémie Roland, PhD – EPI-PHARE
### @@@ Romain Fortuna – EPI-PHARE, French National Agency for Medicines and Health Products Safety (ANSM) and French National Health Insurance (CNAM) ### 2327686###Co-Author######EPI-PHARE, French National Agency for Medicines and Health Products Safety (ANSM) and French National Health Insurance (CNAM)###Co-Author: Romain Fortuna – EPI-PHARE, French National Agency for Medicines and Health Products Safety (ANSM) and French National Health Insurance (CNAM)
### @@@ Rosemary Dray-Spira – EPI-PHARE, French National Agency for Medicines and Health Products Safety (ANSM) and French National Health Insurance (CNAM), 143-147 Boulevard Anatole France, 93285, Saint-Denis, France ### 1093512###Co-Author######EPI-PHARE, French National Agency for Medicines and Health Products Safety (ANSM) and French National Health Insurance (CNAM), 143-147 Boulevard Anatole France, 93285, Saint-Denis, France###Co-Author: Rosemary Dray-Spira – EPI-PHARE, French National Agency for Medicines and Health Products Safety (ANSM) and French National Health Insurance (CNAM), 143-147 Boulevard Anatole France, 93285, Saint-Denis, France
### @@@ Alain Weill, MD – EPI-PHARE, French National Agency for Medicines and Health Products Safety (ANSM) and French National Health Insurance (CNAM), 143-147 Boulevard Anatole France, 93285, Saint-Denis, France ### 1358499###Co-Author###deputy director###EPI-PHARE, French National Agency for Medicines and Health Products Safety (ANSM) and French National Health Insurance (CNAM), 143-147 Boulevard Anatole France, 93285, Saint-Denis, France###Co-Author: Alain Weill, MD – EPI-PHARE, French National Agency for Medicines and Health Products Safety (ANSM) and French National Health Insurance (CNAM), 143-147 Boulevard Anatole France, 93285, Saint-Denis, France
### @@@ Mahmoud Zureik, Phamacoepidemiology professor – EPI-PHARE, French National Agency for Medicines and Health Products Safety (ANSM) and French National Health Insurance (CNAM), 143-147 Boulevard Anatole France, 93285, Saint-Denis, France ### 1358633###Co-Author###Phamacoepidemiology professor###EPI-PHARE, French National Agency for Medicines and Health Products Safety (ANSM) and French National Health Insurance (CNAM), 143-147 Boulevard Anatole France, 93285, Saint-Denis, France###Co-Author: Mahmoud Zureik, Phamacoepidemiology professor – EPI-PHARE, French National Agency for Medicines and Health Products Safety (ANSM) and French National Health Insurance (CNAM), 143-147 Boulevard Anatole France, 93285, Saint-Denis, France
###Presenting Author: Jessica C. Young, PhD (she/her/hers) – CAUSALab at IMM, Karolinska Institutet
### she/her/hers @@@ Issa J. J. Dahabreh – CAUSALab, Harvard T.H. Chan School of Public Health ### 1658425###Co-Author######CAUSALab, Harvard T.H. Chan School of Public Health###Co-Author: Issa J. J. Dahabreh – CAUSALab, Harvard T.H. Chan School of Public Health
### @@@ David Erlinge – Lund University ### 2325259###Co-Author######Lund University###Co-Author: David Erlinge – Lund University
### @@@ Stefan James – Uppsala Clinical Research Center ### 1658428###Co-Author######Uppsala Clinical Research Center###Co-Author: Stefan James – Uppsala Clinical Research Center
### @@@ Ole Fröbert – Department of Medical Sciences ### 1658426###Co-Author######Department of Medical Sciences###Co-Author: Ole Fröbert – Department of Medical Sciences
### @@@ Anita Berglund, PhD – CAUSALab, Unit of Epidemiology, Institute of Environmental Medicine, Karolinska Institutet ### 1658431###Co-Author###Ass Professor###CAUSALab, Unit of Epidemiology, Institute of Environmental Medicine, Karolinska Institutet###Co-Author: Anita Berglund, PhD – CAUSALab, Unit of Epidemiology, Institute of Environmental Medicine, Karolinska Institutet
### @@@ Miguel A. Hernán – CAUSALab, Unit of Epidemiology, Institute of Environmental Medicine, Karolinska Institutet ### 1360646###Co-Author######CAUSALab, Unit of Epidemiology, Institute of Environmental Medicine, Karolinska Institutet###Co-Author: Miguel A. Hernán – CAUSALab, Unit of Epidemiology, Institute of Environmental Medicine, Karolinska Institutet
### @@@ Anthony A. Matthews, PhD – CAUSALab, Unit of Epidemiology, Institute of Environmental Medicine, Karolinska Institutet ### 1658424###Co-Author######CAUSALab, Unit of Epidemiology, Institute of Environmental Medicine, Karolinska Institutet###Co-Author: Anthony A. Matthews, PhD – CAUSALab, Unit of Epidemiology, Institute of Environmental Medicine, Karolinska Institutet
### @@@ Rebecca Rylance – Department of Cardiology, Clinical Sciences, Lund University ### 2325504###Co-Author######Department of Cardiology, Clinical Sciences, Lund University###Co-Author: Rebecca Rylance – Department of Cardiology, Clinical Sciences, Lund University
###